| TTM
|
6/30/2026
|
6/30/2025
|
6/30/2024
|
6/30/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
15,276 | 15,276 | 4,409.3290 | 1,017.7880 | -- |
|
Gross Profit
|
15,276 | 15,276 | 4,409.3290 | 1,017.7880 | -- |
| Selling, General and Administrative Expenses
|
-22,893 | -22,893 | -19,971.8740 | -16,018.9040 | -12,387.4110 |
|
Research and Development Expenses
|
-47,575 | -47,575 | -23,026.4200 | -28,272.9600 | -26,694.7860 |
| Depreciation, Amortization and Depletion
|
-342 | -342 | -396.9870 | -231.6540 | -191.2710 |
| Other Income/Expense, Operating
|
-2,148 | -2,148 | -1,592.1910 | -1,836.6010 | -1,023.5250 |
|
Operating Income/Expenses
|
-72,958 | -72,958 | -44,987.4720 | -46,360.1190 | -40,296.9930 |
|
Total Operating Profit/Loss
|
-57,682 | -57,682 | -40,578.1430 | -45,342.3310 | -40,296.9930 |
| Total Net Finance Income/Expense
|
3,247 | 3,247 | 2,624.0360 | 4,097.0900 | 1,258.8690 |
|
Non-Operating Income/Expenses, Total
|
3,247 | 3,247 | 2,624.0360 | 4,097.0900 | 1,258.8690 |
|
Pretax Income
|
-54,435 | -54,435 | -37,954.1070 | -41,245.2410 | -39,038.1240 |
|
Provision for Income Tax
|
-462 | -462 | -430.6520 | 0 | 0 |
|
Net Income from Continuing Operations
|
-54,897 | -54,897 | -38,384.7590 | -41,245.2410 | -39,038.1240 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-54,897 | -54,897 | -38,384.7590 | -41,245.2410 | -39,038.1240 |
|
Net Income after Non-Controlling/Minority Interests
|
-54,897 | -54,897 | -38,384.7590 | -41,245.2410 | -39,038.1240 |
|
Net Income Available to Common Stockholders
|
-54,897 | -54,897 | -38,384.7590 | -41,245.2410 | -39,038.1240 |
| Basic EPS
|
-0.25 | -0.25 | -0.19 | -0.22 | -0.22 |
| Diluted EPS
|
-0.25 | -0.25 | -0.19 | -0.22 | -0.22 |
|
Basic Weighted Average Shares Outstanding
|
215,728.6840 | 215,728.6840 | 200,322.1920 | 188,045.5370 | 176,051.6870 |
|
Diluted Weighted Average Shares Outstanding
|
215,728.6840 | 215,728.6840 | 200,322.1920 | 188,045.5370 | 176,051.6870 |
| Comprehensive Income
|
|||||
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-57,682 | -57,682 | -40,578.1430 | -45,342.3310 | -40,296.9930 |
|
EBITDA
|
-57,340 | -57,340 | -40,181.1560 | -45,110.6770 | -40,105.7220 |
|
Normalized EBITDA
|
-57,340 | -57,340 | -40,181.1560 | -45,110.6770 | -40,105.7220 |
|
Normalized Income
|
-54,897 | -54,897 | -38,384.7590 | -41,245.2410 | -39,038.1240 |
|
Total Unusual Items
|
0 | 0 | 0 | 0 | 0 |
|
Total Unusual Items Excluding Goodwill
|
0 | 0 | 0 | 0 | 0 |
|
Tax Effect of Unusual Items
|
0 | 0 | 0 | 0 | 0 |
|
Tax Rate, Calculated
|
0.30 | 0.30 | 0.30 | 0.00 | 0.00 |
6/30/2023 - 8/15/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade